Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Vitamin D supplementation in multiple sclerosis patients in 2012: hype or reality as an adjunctive therapy?
Neurodegeneration and inflammation in MS: The eye teaches us about the storm.
Oxidative Modifications of Cerebral Transthyretin are Associated with Multiple Sclerosis.
Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS).
Antiviral therapy of two patients with chromosomally-integrated human herpesvirus-6A presenting with cognitive dysfunction.
IL-4/10 prevents stress vulnerability following imipramine discontinuation.
Transplantation of olfactory ensheathing cells promotes partial recovery in rats with experimental autoimmune encephalomyelitis.
Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15.
[Changes of epidemiological and clinical features and disease concept in multiple sclerosis].
The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis.
Fatigue Management in Multiple Sclerosis.
Neuroantigen-Specific Autoregulatory CD8+ T Cells Inhibit Autoimmune Demyelination through Modulation of Dendritic Cell Function.
Nutrition Facts in Multiple Sclerosis.
Transverse Myelitis Associated with Anti-Ro (SSA) Autoantibodies: A Record of Two Cases.
A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists.
Multiple sclerosis patients and clinical care in Taiwan.
Specialized housing and transportation needs of adults with multiple sclerosis.
Fingolimod Reduces Direct Medical Costs Compared to Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis in the Netherlands.
Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms.
The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo.
Incorporating real-world clinical practice in multiple sclerosis economic evaluations.
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.
Validation of the Social Provisions Scale in People With Multiple Sclerosis.
Evaluation of hemodynamic properties of cerebral venous drainage in patients with multiple sclerosis: a case-control study.
Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis.

Pages